The Boger lab has made a powerful analog of vancomycin that is effective against MRSA and other disease-causing bacteria.
On the occasion of positive new data for RPC1063, Professor Hugh Rosen shares his perspective on the drug candidate, which was initially discovered, synthesized and developed at TSRI.
Professor Jack Johnson was nominated with 22 letters of support from current and former trainees.
“It has added power to many of the technologies we already have on campus," says Professor Luc Teyton.